Clinical Trial: GliomaAI-Oligo: MRI-Based Detection of IDH Mutant Oligodendroglioma

U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673705) titled 'GliomaAI-Oligo: MRI-Based Detection of IDH Mutant Oligodendroglioma' on June 23.

Brief Summary: The goal of this observational study is to learn whether an artificial intelligence system called GliomaAI-Oligo can help detect a specific molecular type of brain tumour called Oligodendroglioma using routine MRI scans. The study uses previously collected and fully anonymised MRI data from 1,372 patients from 13 institutions in the Cancer Imaging Archive (TCIA).

The main questions it aims to answer are:

* How accurately can GliomaAI-Oligo identify Oligodendroglioma from MRI scans?

* How well does the system perform across data from di...